A meta‐analysis evaluated the diagnostic value of CK‐18, FGF‐21 or a combination panel to diagnose NASH and noted highest Sn (92%) and Sp (85%) in the combination panel compared to FGF‐21 along (Sn 62% Sp 78%).40 This evidence concerns the gene KRT18 and metabolic dysfunction-associated steatohepatitis.